Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
BIOGEN INC. (BIIB)
Sector: Healthcare; Industry: Drug Manufacturers—General

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-09 Mantas Jesus B Director Buy 898 $267.00 $239,766 No
2020-11-30 Vounatsos Michel Chief Executive Officer Buy 3,100 $241.31 $748,047 No
2020-11-04 Sandrock Alfred EVP, Research & Development Sell 1,500 $350.00 $525,000 No
2020-03-11 SHERWIN STEPHEN A Director Sell 2,434 $295.22 $718,574 Yes
2019-12-02 Posner Brian S Director Sell 1,055 $292.35 $308,429 No
2019-05-02 DENNER ALEXANDER J Director Buy 118,342 $229.94 $27,211,824 No
2019-05-01 Vounatsos Michel Chief Executive Officer Buy 4,351 $231.48 $1,007,169 No
2019-03-18 PANGIA ROBERT W Director Sell 6,114 $328.55 $2,008,755 Yes
2019-02-01 DENNER ALEXANDER J Director Buy 62,800 $327.59 $20,572,406 No
2018-09-26 Ehlers Michael D EVP, Research and Development Sell 1,000 $350.00 $350,000 No
2018-04-25 DENNER ALEXANDER J Director Buy 48,000 $269.91 $12,955,680 No
2018-02-27 Sandrock Alfred EVP, Chief Medical Officer Sell 259 $290.83 $75,325 No
2018-02-23 Sandrock Alfred EVP, Chief Medical Officer Sell 908 $293.44 $266,444 Yes
2018-02-20 Sandrock Alfred EVP, Chief Medical Officer Sell 743 $292.00 $216,956 No
2018-02-15 Sandrock Alfred EVP, Chief Medical Officer Sell 1,294 $298.85 $386,712 No
2018-01-09 PANGIA ROBERT W Director Sell 5,832 $329.65 $1,922,519 Yes
2017-12-29 Vounatsos Michel Chief Executive Officer Buy 780 $320.55 $250,029 No
2017-11-29 DENNER ALEXANDER J Director Buy 30,000 $317.36 $9,520,800 No
2017-07-25 ALEXANDER SUSAN H EVP Chief Legal Corp Svc & Sec Sell 4,974 $290.01 $1,442,510 No
2017-07-19 ALEXANDER SUSAN H EVP Chief Legal Corp Svc & Sec Sell 7,758 $285.00 $2,211,030 No
2017-06-09 Posner Brian S Director Sell 1,084 $256.31 $277,840 No
2017-05-01 Vounatsos Michel Chief Executive Officer Buy 1,402 $271.35 $380,433 No
2017-04-27 DENNER ALEXANDER J Director Buy 73,858 $278.50 $20,569,476 No
2017-04-25 Clancy Paul J Executive VP and CFO Sell 9,892 $290.00 $2,868,680 No
2017-04-03 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Sell 1,981 $274.08 $542,952 No
2017-03-13 Clancy Paul J Executive VP and CFO Sell 9,891 $291.55 $2,883,721 No
2017-03-01 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Sell 973 $290.07 $282,238 No
2017-02-27 Vounatsos Michel Chief Executive Officer Buy 1,333 $285.39 $380,425 No
2017-01-09 PANGIA ROBERT W Director Sell 5,450 $295.39 $1,609,876 Yes
2016-12-01 Karaboutis Adriana EVP, Tech, Bus. Sol & Corp Aff Sell 48 $296.53 $14,233 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.